CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
65.55
-1.27 (-1.90%)
At close: Apr 28, 2026, 4:00 PM EDT
66.85
+1.30 (1.98%)
After-hours: Apr 28, 2026, 7:47 PM EDT
CG Oncology Employees
CG Oncology had 142 employees as of December 31, 2025. The number of employees increased by 29 or 25.66% compared to the previous year.
Employees
142
Change (1Y)
29
Growth (1Y)
25.66%
Revenue / Employee
$28,451
Profits / Employee
-$1,133,768
Market Cap
5.53B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 142 | 29 | 25.66% |
| Dec 31, 2024 | 113 | 52 | 85.25% |
| Dec 31, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| PTC Therapeutics | 991 |
| Rhythm Pharmaceuticals | 414 |
| Mirum Pharmaceuticals | 372 |
| Immunovant | 362 |
| Cogent Biosciences | 258 |
| Celcuity | 155 |
| Centessa Pharmaceuticals | 118 |
CGON News
- 2 months ago - CG Oncology Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - CG Oncology Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 3 months ago - CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC - GlobeNewsWire
- 4 months ago - CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer - GlobeNewsWire
- 5 months ago - CG Oncology Announces New Board Member and Board Transition - GlobeNewsWire